Bone Marrow TransplantationBone MarrowCord Blood Stem Cell TransplantationBone Marrow CellsTransplantation, HomologousGraft vs Host DiseaseBone and BonesKidney TransplantationHematopoietic Stem Cell TransplantationTransplantation ChimeraTissue DonorsTransplantation ConditioningTransplantation, AutologousFetal BloodHistocompatibility TestingWhole-Body IrradiationHematologic NeoplasmsImmunosuppressive AgentsGraft SurvivalLiver TransplantationAnemia, AplasticBone Marrow DiseasesLeukemiaGraft RejectionHematopoietic Stem CellsBone Marrow PurgingTreatment OutcomeBone Marrow ExaminationBone RemodelingBone Marrow NeoplasmsBusulfanHeart TransplantationCyclosporineHematopoiesisTime FactorsHistocompatibilityMice, Inbred C57BLCyclophosphamideTransplantation, IsogeneicBone DensityImmunosuppressionLung TransplantationRadiation ChimeraRecurrenceTransplantation ImmunologyLeukemia, Myeloid, AcuteCombined Modality TherapyTacrolimusOrgan TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveRetrospective StudiesBone ResorptionColony-Forming Units AssayPrecursor Cell Lymphoblastic Leukemia-LymphomaCytomegalovirus InfectionsHepatic Veno-Occlusive DiseaseTransplantationAcute DiseaseRemission InductionLeukemia, MyeloidStem Cell TransplantationCell DifferentiationT-LymphocytesGraft vs Host ReactionLymphocyte DepletionSurvival AnalysisLymphoma, Non-HodgkinMyelodysplastic SyndromesPostoperative ComplicationsHLA AntigensFollow-Up StudiesChimeraBone NeoplasmsLeukocyte TransfusionHematologic DiseasesFlow CytometryCells, CulturedSevere Combined ImmunodeficiencyTransplantsPancytopeniaSpleenBone DevelopmentImmunocompromised HostBone DiseasesSurvival RateMice, Inbred BALB CMultiple MyelomaLeukocyte CountAntigens, CD34Granulocyte Colony-Stimulating FactorActuarial AnalysisLymphocyte TransfusionAntineoplastic Combined Chemotherapy ProtocolsCyclosporinsGranulocytesAntilymphocyte SerumNuclear FamilyMycophenolic AcidPrognosisCarmustine